Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 4

1(14.3%)

Phase 2

1(14.3%)

7Total

N/A(5)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06213532Not ApplicableRecruiting

CONNECTing to LungCare

Role: collaborator

NCT01941277Not ApplicableTerminated

Effect of Exercise on Insulin Resistance

Role: lead

NCT01434433Completed

Alere Triage fs B-type Natriuretic Peptide (BNP) Method Comparison Evaluation

Role: lead

NCT01347567Not ApplicableCompleted

Heart Failure (HF) Outpatient Monitoring Evaluation (HOME) Study

Role: lead

NCT01291836Completed

Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study

Role: lead

NCT02351063Not ApplicableTerminated

HF Assessment With BNP in the Home: Part II

Role: lead

NCT01032278Not ApplicableUnknown

Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

Role: collaborator

NCT01557361Phase 2Completed

Standard Versus Accelerated Initiation of Dialysis in Acute Kidney Injury

Role: collaborator

NCT01374880Unknown

Diagnostic and Prognostic Value of New Biomarkers in Patients With Heart Disease

Role: collaborator

NCT01563250Phase 4Completed

Improving the Management of Acute Coronary Syndromes in the Emergency Department

Role: collaborator

All 10 trials loaded